mail
versión imprimible
 
 

3rd Annual Ligase Targeting Drug Development Summit

Evvnt Promotion / evvnt
-
11.04.2023 - 13.04.2023  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 am to 5:00 pm
 
Temas de la conferencia
From discovery to clinical development, the field of protein degradation is booming with excitement, with a whole host of investments and new companies joining the effort to successfully degrade unwanted or undrugged targets with key roles in a broad range of diseases from oncology to CNS, through to autoimmune.

Despite this, key challenges remain to rapidly and successfully discover novel and underexploited Ubiquitin E3 ligases.
La Sociedad Científica
Hanson Wade
Observaciones
Speakers: Kirby Swatek, Principal Investigator, University of Dundee, Ian Churcher, Chief Scientific Officer, Amphista Therapeutics, David Duda, Senior Scientist, Johnson and Johnson and more.
 

Información e inscripción:

https://go.evvnt.com/1450513-2?pid=4832
Mr. Alex Domingo
 
Categorías
Salud Pública, Servicios de salud
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5846.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Österreichisches Rotes KreuzAlumni Club Medizinische Universität WienÄrzte der WeltAGEM - Arbeitsgemeinschaft Ethnologie und MedizinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Anästhesie in Entwicklungsländern e. V.newTreeCenter of Excellence